Feature image

What's New

New Prescriber Update edition published

We've published the latest edition of Prescriber Update.

This edition includes: medicine safety information for empagliflozin, fingolimod, amiloride, spironolactone, sodium valproate, and more

Prescriber Update Vol. 42 No. 3 - September 2021

News and Events

Date Type Title
15/9/2021COVID-19 Adverse events following immunisation with COVID-19 vaccines: Safety Report #26 – 28 August 2021
8/9/2021COVID-19 Adverse events following immunisation with COVID-19 vaccines: Safety Report #25 – 21 August 2021
6/9/2021Alert CommunicationRisks of importing or prescribing ivermectin for prevention or treatment of COVID-19
6/9/2021CommitteesAgenda for the 67th Medicines Classification Committee meeting
2/9/2021PublicationsPrescriber Update Vol. 42 No. 3 – September 2021
1/9/2021COVID-19 Adverse events following immunisation with COVID-19 vaccines: Safety Report #24 – 14 August 2021
30/8/2021CommitteesAgenda for the 187th Medicines Adverse Reactions Committee meeting - 9 September 2021
25/8/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #23 – 7 August 2021
18/8/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #22 – 31 July 2021
12/8/2021Monitoring CommunicationDihydrocodeine: review of risks and benefits
11/8/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #21 – 24 July 2021
9/8/2021CommitteesMedicines Classification Committee - Dates and Deadlines
9/8/2021CommitteesMinutes of the 66th meeting of the Medicines Classification Committee - 11 May 2021
4/8/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #20 – 17 July 2021
28/7/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #19 – 10 July 2021
21/7/2021COVID-19Adverse events following immunisation with COVID-19 vaccines: Safety Report #18 – 3 July 2021
21/7/2021Alert CommunicationMyocarditis and pericarditis - rare adverse reactions to Comirnaty (Pfizer COVID-19 vaccine)